Anika Therapeutics Inc (ANIK) financials · rev $112.8M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Anika Therapeutics Inc (ANIK) rev $112.8M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $112.8M | $119.9M |
| Cost of Revenue | $49.0M | $43.9M |
| Gross Profit | $63.8M | $76.0M |
| Operating Income | -$11.1M | -$5.10M |
| Net Income | -$10.9M | -$56.4M |
| EPS (Diluted) | -$0.76 | -$3.83 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $190.3M | $202.7M |
| Current Assets | $103.4M | $113.7M |
| Cash & Equivalents | $57.5M | $55.6M |
| Inventory | $18.8M | $23.8M |
| PP&E | $40.3M | $39.0M |
| Total Liabilities | $46.8M† | $48.8M† |
| Current Liabilities | $21.9M | $23.3M |
| Shareholders' Equity | $143.5M | $154.0M |
| Retained Earnings | $60.8M | $71.7M |
† Total Liabilities: Derived: total assets minus shareholders’ equity (stored total liabilities equalled total assets, i.e. the liabilities-and-equity total).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $11.2M | $5.40M |
| CapEx | $6.83M | $7.73M |
| Investing Cash Flow | -$401.0K | -$8.33M |
| Financing Cash Flow | -$10.6M | -$12.7M |
| Net Change in Cash | $322.0K | -$15.7M |
| Free Cash Flow | $4.36M | -$2.33M |
FAQ
What is ANIK P/E and revenue?
Anika Therapeutics Inc (ANIK) rev $112.8M.
What is ANIK revenue?
Anika Therapeutics Inc last cached revenue is $112.8M (FY2025).
Is ANIK profitable?
Anika Therapeutics Inc last cached net income is -$10.9M (FY2025).
What are ANIK total assets?
Anika Therapeutics Inc last cached total assets are $190.3M (FY2025).
What is ANIK free cash flow?
Anika Therapeutics Inc last cached free cash flow is $4.36M (FY2025).
Not investment advice. Cached statements, not a live tape.